These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 10402233)
1. Cell cycle effects and control of gene expression by resveratrol in human breast carcinoma cell lines with different metastatic potentials. Hsieh TC; Burfeind P; Laud K; Backer JM; Traganos F; Darzynkiewicz Z; Wu JM Int J Oncol; 1999 Aug; 15(2):245-52. PubMed ID: 10402233 [TBL] [Abstract][Full Text] [Related]
2. Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer. Palmieri D; Halverson DO; Ouatas T; Horak CE; Salerno M; Johnson J; Figg WD; Hollingshead M; Hursting S; Berrigan D; Steinberg SM; Merino MJ; Steeg PS J Natl Cancer Inst; 2005 May; 97(9):632-42. PubMed ID: 15870434 [TBL] [Abstract][Full Text] [Related]
3. Dexamethasone and medroxyprogesterone acetate elevate Nm23-H1 metastasis suppressor gene expression in metastatic human breast carcinoma cells: new uses for old compounds. Ouatas T; Halverson D; Steeg PS Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3763-72. PubMed ID: 14506169 [TBL] [Abstract][Full Text] [Related]
4. Comparative effects of retinoic acid, vitamin D and resveratrol alone and in combination with adenosine analogues on methylation and expression of phosphatase and tensin homologue tumour suppressor gene in breast cancer cells. Stefanska B; Salamé P; Bednarek A; Fabianowska-Majewska K Br J Nutr; 2012 Mar; 107(6):781-90. PubMed ID: 21801466 [TBL] [Abstract][Full Text] [Related]
5. A novel function for the nm23-H1 gene: overexpression in human breast carcinoma cells leads to the formation of basement membrane and growth arrest. Howlett AR; Petersen OW; Steeg PS; Bissell MJ J Natl Cancer Inst; 1994 Dec; 86(24):1838-44. PubMed ID: 7990158 [TBL] [Abstract][Full Text] [Related]
6. P53 is a regulator of the metastasis suppressor gene Nm23-H1. Chen SL; Wu YS; Shieh HY; Yen CC; Shen JJ; Lin KH Mol Carcinog; 2003 Apr; 36(4):204-14. PubMed ID: 12669312 [TBL] [Abstract][Full Text] [Related]
7. The antiproliferative activity of resveratrol results in apoptosis in MCF-7 but not in MDA-MB-231 human breast cancer cells: cell-specific alteration of the cell cycle. Pozo-Guisado E; Alvarez-Barrientos A; Mulero-Navarro S; Santiago-Josefat B; Fernandez-Salguero PM Biochem Pharmacol; 2002 Nov; 64(9):1375-86. PubMed ID: 12392819 [TBL] [Abstract][Full Text] [Related]
8. Regulation of p53 and cell proliferation by resveratrol and its derivatives in breast cancer cells: an in silico and biochemical approach targeting integrin αvβ3. Hsieh TC; Wong C; John Bennett D; Wu JM Int J Cancer; 2011 Dec; 129(11):2732-43. PubMed ID: 21225623 [TBL] [Abstract][Full Text] [Related]
9. Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: effects on tumor metastatic potential, colonization and enzymatic activity. Leone A; Flatow U; VanHoutte K; Steeg PS Oncogene; 1993 Sep; 8(9):2325-33. PubMed ID: 8395676 [TBL] [Abstract][Full Text] [Related]
10. Elevation of breast carcinoma Nm23-H1 metastasis suppressor gene expression and reduced motility by DNA methylation inhibition. Hartsough MT; Clare SE; Mair M; Elkahloun AG; Sgroi D; Osborne CK; Clark G; Steeg PS Cancer Res; 2001 Mar; 61(5):2320-7. PubMed ID: 11280805 [TBL] [Abstract][Full Text] [Related]
11. A novel resveratrol-salinomycin combination sensitizes ER-positive breast cancer cells to apoptosis. Venkatadri R; Iyer AKV; Kaushik V; Azad N Pharmacol Rep; 2017 Aug; 69(4):788-797. PubMed ID: 28605700 [TBL] [Abstract][Full Text] [Related]
12. Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2. Horak CE; Lee JH; Elkahloun AG; Boissan M; Dumont S; Maga TK; Arnaud-Dabernat S; Palmieri D; Stetler-Stevenson WG; Lacombe ML; Meltzer PS; Steeg PS Cancer Res; 2007 Aug; 67(15):7238-46. PubMed ID: 17671192 [TBL] [Abstract][Full Text] [Related]
13. Resveratrol analog trans 3,4,5,4'-tetramethoxystilbene (DMU-212) mediates anti-tumor effects via mechanism different from that of resveratrol. Ma Z; Molavi O; Haddadi A; Lai R; Gossage RA; Lavasanifar A Cancer Chemother Pharmacol; 2008 Dec; 63(1):27-35. PubMed ID: 18286288 [TBL] [Abstract][Full Text] [Related]
14. Resveratrol attenuates the anticancer efficacy of paclitaxel in human breast cancer cells in vitro and in vivo. Fukui M; Yamabe N; Zhu BT Eur J Cancer; 2010 Jul; 46(10):1882-91. PubMed ID: 20223651 [TBL] [Abstract][Full Text] [Related]
15. Riccardin D, a macrocyclic bisbibenzy, inhibits human breast cancer growth through the suppression of telomerase activity. Sun CC; Xu HM; Yuan Y; Gao ZH; Lou HX; Qu XJ Basic Clin Pharmacol Toxicol; 2014 Dec; 115(6):488-98. PubMed ID: 24836118 [TBL] [Abstract][Full Text] [Related]
16. Resveratrol augments paclitaxel treatment in MDA-MB-231 and paclitaxel-resistant MDA-MB-231 breast cancer cells. Sprouse AA; Herbert BS Anticancer Res; 2014 Oct; 34(10):5363-74. PubMed ID: 25275030 [TBL] [Abstract][Full Text] [Related]
17. Expression profile of genes associated with antimetastatic gene: nm23-mediated metastasis inhibition in breast carcinoma cells. Zhao H; Jhanwar-Uniyal M; Datta PK; Yemul S; Ho L; Khitrov G; Kupershmidt I; Pasinetti GM; Ray T; Athwal RS; Achary MP Int J Cancer; 2004 Mar; 109(1):65-70. PubMed ID: 14735469 [TBL] [Abstract][Full Text] [Related]
18. Resveratrol induces growth inhibition and apoptosis in metastatic breast cancer cells via de novo ceramide signaling. Scarlatti F; Sala G; Somenzi G; Signorelli P; Sacchi N; Ghidoni R FASEB J; 2003 Dec; 17(15):2339-41. PubMed ID: 14563682 [TBL] [Abstract][Full Text] [Related]